Search

everythinglearnresearchcommunity

for

Search:↓

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Found microRNA differences in hair cells, suggesting potential treatment targets for hair loss.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

High testosterone increases heart disease risk in women with PCOS.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Hypothyroidism may cause certain types of hair loss.

Certain mutations in a hair growth-related gene cause a type of genetic hair loss.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Iron deficiency may contribute to hair loss.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

A new therapy for a skin blistering condition has not been developed yet.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Skin bacteria can help wound healing by activating certain immune cells.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Melasma treatment is difficult, but combination therapies and personalized plans show promise.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

CD2 might be a new treatment target for patchy alopecia areata.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Treatments for melanin disorders exist, but more effective options needed.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

UV-B light increases inflammation-related substances in acne-related skin cells.

Creating fully functional artificial skin for chronic wounds is still very challenging.